Bilgin Comert Selected Research

Acute Necrotizing Pancreatitis

5/2012	Effects of infliximab on bacterial translocation in experimental acute necrotizing pancreatitis.
12/2007	Combination of allopurinol and hyperbaric oxygen therapy: a new treatment in experimental acute necrotizing pancreatitis?
12/2006	The role of allopurinol in experimental acute necrotizing pancreatitis.
4/2006	Acinar cell ultrastructure after taurine treatment in rat acute necrotizing pancreatitis.
10/2005	Hyperbaric oxygen-induced changes in bacterial translocation and acinar ultrastructure in rat acute necrotizing pancreatitis.
6/2005	The effect of activated protein C on experimental acute necrotizing pancreatitis.
1/2004	The effect of combination therapy of hyperbaric oxygen, meropenem, and selective nitric oxide synthase inhibitor in experimental acute pancreatitis.
10/2003	Deferoxamine and meropenem combination therapy in experimental acute pancreatitis.
5/2003	The effect of antibiotic and probiotic combination therapy on secondary pancreatic infections and oxidative stress parameters in experimental acute necrotizing pancreatitis.
5/2003	The role of inducible nitric oxide synthase inhibitor, meropenem, and taurine in experimental acute necrotizing pancreatitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bilgin Comert Research Topics

Disease

12	Pancreatitis 03/2015 - 11/2002
12	Acute Necrotizing Pancreatitis 05/2012 - 11/2002
5	Liver Cirrhosis (Hepatic Cirrhosis) 08/2008 - 04/2004
5	Fibrosis (Cirrhosis) 08/2008 - 03/2006
3	Necrosis 05/2012 - 06/2005
3	Fat Necrosis 05/2012 - 06/2005
3	Infections 10/2003 - 01/2003
2	Inflammation (Inflammations) 05/2012 - 06/2005
2	Chronic Pancreatitis 11/2007 - 07/2006
2	Gallstones (Gallstone) 08/2007 - 01/2002
2	Superinfection 10/2005 - 06/2005
1	Neoplasms (Cancer) 12/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Subcutaneous Emphysema 12/2021
1	Mediastinal Emphysema (Pneumomediastinum) 12/2021
1	Disease Progression 01/2020
1	Human Influenza (Influenza) 01/2020
1	Hyperoxia 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Dyspnea (Shortness of Breath) 11/2012
1	Atrophy 11/2007
1	Weight Loss (Weight Reduction) 07/2006
1	Sepsis (Septicemia) 06/2005

Drug/Important Bio-Agent (IBA)

6	Taurine FDA Link 08/2008 - 05/2003
6	Taurocholic Acid (Sodium Taurocholate)IBA 12/2006 - 11/2002
5	Oxygen (Dioxygen)IBA 01/2020 - 01/2004
5	Meropenem (Merrem)FDA LinkGeneric 01/2004 - 01/2003
3	Atrial Natriuretic Factor (ANF)IBA 11/2012 - 01/2003
3	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2008 - 03/2006
3	Allopurinol (Remid)FDA LinkGeneric 12/2007 - 12/2006
3	AntioxidantsIBA 11/2007 - 04/2004
3	salicylhydroxamic acid (SHAM)IBA 12/2006 - 05/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2003 - 01/2003
2	Free RadicalsIBA 11/2007 - 07/2006
2	Bile Acids and Salts (Bile Acids)IBA 08/2007 - 01/2002
2	CholesterolIBA 08/2007 - 01/2002
2	Hydroxyproline (4 Hydroxyproline)IBA 06/2007 - 03/2006
2	Proteins (Proteins, Gene)FDA Link 04/2004 - 01/2002
2	S-methylisothiopseudouroniumIBA 01/2004 - 05/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2003 - 11/2002
2	Ciprofloxacin (Cipro)FDA LinkGeneric 05/2003 - 01/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2021
1	Panitumumab (Vectibix)FDA Link 12/2021
1	Fluorouracil (Carac)FDA LinkGeneric 12/2021
1	Leucovorin (Folinic Acid)FDA Link 12/2021
1	3-aminobenzamideIBA 03/2015
1	AdrenomedullinIBA 11/2012
1	ProcalcitoninIBA 11/2012
1	Amylases FDA Link 05/2012
1	Infliximab (Remicade)FDA Link 05/2012
1	Saline SolutionIBA 05/2012
1	Xanthine OxidaseIBA 11/2007
1	CollagenIBA 11/2007
1	Interferon-alpha (Interferon Alfa)IBA 06/2007
1	Tissue Inhibitor of Metalloproteinase-1IBA 03/2006
1	InterferonsIBA 03/2006
1	vasectrin II (VS II)IBA 03/2006
1	Protein CIBA 06/2005
1	Biomarkers (Surrogate Marker)IBA 06/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2004
1	Deferoxamine (Desferal)FDA LinkGeneric 10/2003
1	Drug CombinationsIBA 05/2003
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2003
1	Enzyme Precursors (Zymogens)IBA 11/2002
1	EnzymesIBA 11/2002
1	Superoxide DismutaseIBA 11/2002
1	Cholecystokinin (Pancreozymin)IBA 01/2002
1	LecithinsIBA 01/2002
1	Erythromycin (Erycette)FDA LinkGeneric 01/2002

Therapy/Procedure

8	Therapeutics 01/2020 - 05/2003
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 01/2020
2	Hyperbaric Oxygenation 12/2007 - 10/2005
1	Molecular Targeted Therapy 12/2021
1	Length of Stay 01/2020
1	Cannula 01/2020
1	Antibiotic Prophylaxis 01/2003